Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 6/2017

21.11.2016 | Original Article

The association of testosterone, sex hormone-binding globulin, and insulin-like growth factor-1 with bone parameters in Korean men aged 50 years or older

verfasst von: Hye-Jung Kim, Hyung Suk Koo, Young-Sang Kim, Moon Jong Kim, Kwang-Min Kim, Nam-Seok Joo, Ji-hee Haam

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Testosterone and insulin-like growth factor-1 (IGF-1) are essential factors for the maintenance of bone health in men. However, the results for the association of testosterone and IGF-1 with bone parameters were not consistent in prior studies. We evaluated the relationship of testosterone, sex hormone-binding globulin (SHBG), and IGF-1 with bone mineral density (BMD) and bone turnover markers (BTMs) in Korean men. We enrolled 1227 men aged ≥50 years in this cross-sectional study. Serum levels of total testosterone (TT), SHBG, IGF-1, osteocalcin, and C-terminal cross-linking telopeptide of type I collagen (CTX) were measured. Free testosterone (FT) was calculated using Vermeulen’s method. BMD was measured by dual-energy X-ray absorptiometry. TT level was not related to BMD or BTMs in the unadjusted model; however, after adjusting for SHBG and IGF-1, the association between TT and BTMs was significant (β = −0.139 for osteocalcin and β = −0.204 for CTX). SHBG levels were negatively associated with lumbar BMD, and positively associated with BTMs in all models. As SHBG level increased, the prevalence of osteopenia or osteoporosis defined by BMD significantly increased (OR of 1SD change, 1.24). IGF-1 levels were significantly related with BMD, but not with BTMs. Meanwhile, FT levels were positively associated with BMD and negatively associated with BTMs. In conclusion, SHBG levels were independently related with bone parameters and osteopenia in men aged ≥50 years. IGF-1 levels were positively associated with BMD, but not with BTMs. SHBG may play a role in regulating age-related bone loss in men after middle-age.
Literatur
1.
Zurück zum Zitat Bachrach LK (2001) Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 12:22–28CrossRefPubMed Bachrach LK (2001) Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 12:22–28CrossRefPubMed
3.
Zurück zum Zitat Alibhai SM, Gogov S, Allibhai Z (2006) Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 60:201–215CrossRefPubMed Alibhai SM, Gogov S, Allibhai Z (2006) Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 60:201–215CrossRefPubMed
4.
Zurück zum Zitat Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ (1989) Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 69:523–527CrossRefPubMed Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ (1989) Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 69:523–527CrossRefPubMed
5.
Zurück zum Zitat Lee EY, Kim D, Kim KM, Kim KJ, Choi HS, Rhee Y, Lim SK (2012) Age-related bone mineral density patterns in Koreans (KNHANES IV). J Clin Endocrinol Metab 97:3310–3318CrossRefPubMed Lee EY, Kim D, Kim KM, Kim KJ, Choi HS, Rhee Y, Lim SK (2012) Age-related bone mineral density patterns in Koreans (KNHANES IV). J Clin Endocrinol Metab 97:3310–3318CrossRefPubMed
6.
Zurück zum Zitat Iranmanesh A, Lizarralde G, Veldhuis JD (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081–1088CrossRefPubMed Iranmanesh A, Lizarralde G, Veldhuis JD (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081–1088CrossRefPubMed
7.
Zurück zum Zitat Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of A (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724–731CrossRef Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of A (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724–731CrossRef
8.
Zurück zum Zitat Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87:589–598CrossRefPubMed Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87:589–598CrossRefPubMed
9.
Zurück zum Zitat Yeap BB, Almeida OP, Hyde Z, Norman PE, Chubb SA, Jamrozik K, Flicker L (2007) In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study. Eur J Endocrinol 156:585–594CrossRefPubMed Yeap BB, Almeida OP, Hyde Z, Norman PE, Chubb SA, Jamrozik K, Flicker L (2007) In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study. Eur J Endocrinol 156:585–594CrossRefPubMed
10.
Zurück zum Zitat Pye SR, Almusalam B, Boonen S, Vanderschueren D, Borghs H et al (2011) Influence of insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 on bone health: results from the European Male Ageing Study. Calcif Tissue Int 88:503–510CrossRefPubMedPubMedCentral Pye SR, Almusalam B, Boonen S, Vanderschueren D, Borghs H et al (2011) Influence of insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 on bone health: results from the European Male Ageing Study. Calcif Tissue Int 88:503–510CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Szulc P, Joly-Pharaboz MO, Marchand F, Delmas PD (2004) Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. Calcif Tissue Int 74:322–329CrossRefPubMed Szulc P, Joly-Pharaboz MO, Marchand F, Delmas PD (2004) Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. Calcif Tissue Int 74:322–329CrossRefPubMed
12.
Zurück zum Zitat Cauley JA, Ewing SK, Taylor BC, Fink HA, Ensrud KE, Bauer DC, Barrett-Connor E, Marshall L, Orwoll ES, Osteoporotic Fractures in Men Study Research G (2010) Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density—the osteoporotic fractures in men study. J Clin Endocrinol Metab 95:4314–4323CrossRefPubMedPubMedCentral Cauley JA, Ewing SK, Taylor BC, Fink HA, Ensrud KE, Bauer DC, Barrett-Connor E, Marshall L, Orwoll ES, Osteoporotic Fractures in Men Study Research G (2010) Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density—the osteoporotic fractures in men study. J Clin Endocrinol Metab 95:4314–4323CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Paller CJ, Shiels MS, Rohrmann S, Basaria S, Rifai N, Nelson W, Platz EA, Dobs A (2009) Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clin Endocrinol (Oxf) 70:26–34CrossRef Paller CJ, Shiels MS, Rohrmann S, Basaria S, Rifai N, Nelson W, Platz EA, Dobs A (2009) Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clin Endocrinol (Oxf) 70:26–34CrossRef
14.
Zurück zum Zitat Kuchuk NO, van Schoor NM, Pluijm SM, Smit JH, de Ronde W, Lips P (2007) The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women. Clin Endocrinol (Oxf) 67:295–303CrossRef Kuchuk NO, van Schoor NM, Pluijm SM, Smit JH, de Ronde W, Lips P (2007) The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women. Clin Endocrinol (Oxf) 67:295–303CrossRef
15.
Zurück zum Zitat Boonen S, Pye SR, O’Neill TW, Szulc P, Gielen E et al (2011) Influence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European Male Ageing Study (EMAS). Eur J Endocrinol 165:977–986CrossRefPubMed Boonen S, Pye SR, O’Neill TW, Szulc P, Gielen E et al (2011) Influence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European Male Ageing Study (EMAS). Eur J Endocrinol 165:977–986CrossRefPubMed
16.
Zurück zum Zitat Hsu B, Cumming RG, Seibel MJ, Naganathan V, Blyth FM, Bleicher K, Dave A, Le Couteur DG, Waite LM, Handelsman DJ (2015) Reproductive hormones and longitudinal change in bone mineral density and incident fracture risk in older men: the concord health and aging in men project. J Bone Miner Res 30:1701–1708CrossRefPubMed Hsu B, Cumming RG, Seibel MJ, Naganathan V, Blyth FM, Bleicher K, Dave A, Le Couteur DG, Waite LM, Handelsman DJ (2015) Reproductive hormones and longitudinal change in bone mineral density and incident fracture risk in older men: the concord health and aging in men project. J Bone Miner Res 30:1701–1708CrossRefPubMed
17.
Zurück zum Zitat Vanderschueren D, Pye SR, Venken K, Borghs H, Gaytant J et al (2010) Gonadal sex steroid status and bone health in middle-aged and elderly European men. Osteoporos Int 21:1331–1339CrossRefPubMed Vanderschueren D, Pye SR, Venken K, Borghs H, Gaytant J et al (2010) Gonadal sex steroid status and bone health in middle-aged and elderly European men. Osteoporos Int 21:1331–1339CrossRefPubMed
18.
Zurück zum Zitat Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666–3672CrossRefPubMed Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666–3672CrossRefPubMed
19.
Zurück zum Zitat Ferlin A, Selice R, Carraro U, Foresta C (2013) Testicular function and bone metabolism—beyond testosterone. Nat Rev Endocrinol 9:548–554CrossRefPubMed Ferlin A, Selice R, Carraro U, Foresta C (2013) Testicular function and bone metabolism—beyond testosterone. Nat Rev Endocrinol 9:548–554CrossRefPubMed
20.
Zurück zum Zitat Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES (2006) Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 91:3908–3915CrossRefPubMed Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES (2006) Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 91:3908–3915CrossRefPubMed
21.
Zurück zum Zitat Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C (2006) Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 21:529–535CrossRefPubMed Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C (2006) Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 21:529–535CrossRefPubMed
22.
Zurück zum Zitat Rucker D, Ezzat S, Diamandi A, Khosravi J, Hanley DA (2004) IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. Clin Endocrinol (Oxf) 60:491–499CrossRef Rucker D, Ezzat S, Diamandi A, Khosravi J, Hanley DA (2004) IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. Clin Endocrinol (Oxf) 60:491–499CrossRef
23.
Zurück zum Zitat Zha XY, Hu Y, Pang XN, Zhu JH, Chang GL, Li L (2014) Sex hormone-binding globulin (SHBG) as an independent determinant of bone mineral density (BMD) among Chinese middle-aged and elderly men. Endocrine 47:590–597CrossRefPubMed Zha XY, Hu Y, Pang XN, Zhu JH, Chang GL, Li L (2014) Sex hormone-binding globulin (SHBG) as an independent determinant of bone mineral density (BMD) among Chinese middle-aged and elderly men. Endocrine 47:590–597CrossRefPubMed
24.
Zurück zum Zitat Keles I, Aydin G, Basar MM, Hayran M, Atalar E, Orkun S, Batislam E (2006) Endogenous sex steroids and bone mineral density in healthy men. Joint Bone Spine 73:80–85CrossRefPubMed Keles I, Aydin G, Basar MM, Hayran M, Atalar E, Orkun S, Batislam E (2006) Endogenous sex steroids and bone mineral density in healthy men. Joint Bone Spine 73:80–85CrossRefPubMed
25.
Zurück zum Zitat Bo T, Zhu JM (2014) Low levels of free testosterone correlated with bone mineral densities of femoral necks in aged healthy Shanghainese men. Horm Metab Res 46:697–701CrossRefPubMed Bo T, Zhu JM (2014) Low levels of free testosterone correlated with bone mineral densities of femoral necks in aged healthy Shanghainese men. Horm Metab Res 46:697–701CrossRefPubMed
26.
Zurück zum Zitat Vandenput L, Mellstrom D, Kindmark A, Johansson H, Lorentzon M, Leung J, Redlund-Johnell I, Rosengren BE, Karlsson MK, Wang YX, Kwok T, Ohlsson C (2016) High serum SHBG predicts incident vertebral fractures in elderly men. J Bone Miner Res 31:683–689CrossRefPubMedPubMedCentral Vandenput L, Mellstrom D, Kindmark A, Johansson H, Lorentzon M, Leung J, Redlund-Johnell I, Rosengren BE, Karlsson MK, Wang YX, Kwok T, Ohlsson C (2016) High serum SHBG predicts incident vertebral fractures in elderly men. J Bone Miner Res 31:683–689CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Cawthon PM, Schousboe JT, Harrison SL, Ensrud KE, Black D, Cauley JA, Cummings SR, LeBlanc ES, Laughlin GA, Nielson CM, Broughton A, Kado DM, Hoffman AR, Jamal SA, Barrett-Connor E, Orwoll ES, Osteoporotic Fractures in Men Study Research G (2016) Sex hormones, sex hormone binding globulin, and vertebral fractures in older men. Bone 84:271–278CrossRefPubMedPubMedCentral Cawthon PM, Schousboe JT, Harrison SL, Ensrud KE, Black D, Cauley JA, Cummings SR, LeBlanc ES, Laughlin GA, Nielson CM, Broughton A, Kado DM, Hoffman AR, Jamal SA, Barrett-Connor E, Orwoll ES, Osteoporotic Fractures in Men Study Research G (2016) Sex hormones, sex hormone binding globulin, and vertebral fractures in older men. Bone 84:271–278CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Dunn JF, Nisula BC, Rodbard D (1981) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 53:58–68CrossRefPubMed Dunn JF, Nisula BC, Rodbard D (1981) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 53:58–68CrossRefPubMed
30.
Zurück zum Zitat Rosner W, Hryb DJ, Kahn SM, Nakhla AM, Romas NA (2010) Interactions of sex hormone-binding globulin with target cells. Mol Cell Endocrinol 316:79–85CrossRefPubMed Rosner W, Hryb DJ, Kahn SM, Nakhla AM, Romas NA (2010) Interactions of sex hormone-binding globulin with target cells. Mol Cell Endocrinol 316:79–85CrossRefPubMed
32.
Zurück zum Zitat Bredella MA, Gerweck AV, Barber LA, Breggia A, Rosen CJ, Torriani M, Miller KK (2014) Effects of growth hormone administration for 6 months on bone turnover and bone marrow fat in obese premenopausal women. Bone 62:29–35CrossRefPubMedPubMedCentral Bredella MA, Gerweck AV, Barber LA, Breggia A, Rosen CJ, Torriani M, Miller KK (2014) Effects of growth hormone administration for 6 months on bone turnover and bone marrow fat in obese premenopausal women. Bone 62:29–35CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Sneppen SB, Hoeck HC, Kollerup G, Sorensen OH, Laurberg P, Feldt-Rasmussen U (2002) Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults–an 18-month randomised, placebo-controlled, double blinded trial. Eur J Endocrinol 146:187–195CrossRefPubMed Sneppen SB, Hoeck HC, Kollerup G, Sorensen OH, Laurberg P, Feldt-Rasmussen U (2002) Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults–an 18-month randomised, placebo-controlled, double blinded trial. Eur J Endocrinol 146:187–195CrossRefPubMed
34.
Zurück zum Zitat Niemann I, Hannemann A, Nauck M, Spielhagen C, Volzke H, Wallaschofski H, Friedrich N (2013) The association between insulin-like growth factor I and bone turnover markers in the general adult population. Bone 56:184–190CrossRefPubMed Niemann I, Hannemann A, Nauck M, Spielhagen C, Volzke H, Wallaschofski H, Friedrich N (2013) The association between insulin-like growth factor I and bone turnover markers in the general adult population. Bone 56:184–190CrossRefPubMed
35.
Zurück zum Zitat Amin S, Riggs BL, Melton LJ 3rd, Achenbach SJ, Atkinson EJ, Khosla S (2007) High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. J Bone Miner Res 22:799–807CrossRefPubMed Amin S, Riggs BL, Melton LJ 3rd, Achenbach SJ, Atkinson EJ, Khosla S (2007) High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. J Bone Miner Res 22:799–807CrossRefPubMed
36.
Zurück zum Zitat Gurlek A, Gedik O (2001) Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover. J Endocrinol Invest 24:408–414CrossRefPubMed Gurlek A, Gedik O (2001) Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover. J Endocrinol Invest 24:408–414CrossRefPubMed
37.
Zurück zum Zitat Botella S, Restituto P, Monreal I, Colina I, Calleja A, Varo N (2013) Traditional and novel bone remodeling markers in premenopausal and postmenopausal women. J Clin Endocrinol Metab 98:E1740–E1748CrossRefPubMed Botella S, Restituto P, Monreal I, Colina I, Calleja A, Varo N (2013) Traditional and novel bone remodeling markers in premenopausal and postmenopausal women. J Clin Endocrinol Metab 98:E1740–E1748CrossRefPubMed
38.
Zurück zum Zitat Hsing AW, Stanczyk FZ, Belanger A, Schroeder P, Chang L, Falk RT, Fears TR (2007) Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev 16:1004–1008CrossRefPubMed Hsing AW, Stanczyk FZ, Belanger A, Schroeder P, Chang L, Falk RT, Fears TR (2007) Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev 16:1004–1008CrossRefPubMed
Metadaten
Titel
The association of testosterone, sex hormone-binding globulin, and insulin-like growth factor-1 with bone parameters in Korean men aged 50 years or older
verfasst von
Hye-Jung Kim
Hyung Suk Koo
Young-Sang Kim
Moon Jong Kim
Kwang-Min Kim
Nam-Seok Joo
Ji-hee Haam
Publikationsdatum
21.11.2016
Verlag
Springer Japan
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 6/2017
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-016-0803-6

Weitere Artikel der Ausgabe 6/2017

Journal of Bone and Mineral Metabolism 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.